Skip to content
OpenCapital
Get started

Beam Therapeutics BEAM Q3 2025 earnings

Reported November 4, 2025 · Before market open

Revenue$9.7MMiss by $3.5M
EPS-$1.10Miss by $0.12
Revenue estimate$13.2M
EPS estimate-$0.98

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$16.4M
EPS estimate-$1.11

Financials

Q3 2025

Income statement

See full
Revenue$9.7M-32.0%
Operating income-$126.8M-19.1%
Net income-$112.7M-16.6%
EPS (diluted)-$1.10+6.0%

Balance sheet

See full
Cash & equivalents$268.0M+16.4%
Total debt$151.4M-6.6%
Total equity$966.0M+22.1%
Total assets$1.3B+11.9%

Cash flow

See full
Operating cash flow-$81.5M+7.5%
CapEx$5.0M+218%
Free cash flow-$86.5M+3.6%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$2.46B+21.6%
Enterprise value$2.34B+19.9%
P/S44.1×+38.3×

Profitability

See full
Operating margin-837.1%—
Net margin-742.7%—
FCF margin-632.6%—

Returns & leverage

See full
Return on equity-47.1%—
Debt / equity0.2×0.0×
Current ratio6×+0.3×

Versus estimates

Revenue

Q1 2026$31.7MBeat by $20.8MQ4 2025$114.1MBeat by $102.4M
Q3 2025$9.7MMiss by $3.5M
Q2 2025$8.5MMiss by $3.1MQ1 2025$7.5MMiss by $8.0MQ4 2024$30.1MBeat by $13.6M

Diluted EPS

Q1 2026-$0.91Miss by $0.04Q4 2025-$0.10Beat by $1.03
Q3 2025-$1.10Miss by $0.12
Q2 2025-$1.00Beat by $0.04Q1 2025-$1.24Miss by $0.13Q4 2024-$1.09Beat by $0.16

Ask the moment Beam Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Beam Therapeutics report Q3 2025 earnings?
Beam Therapeutics (BEAM) reported Q3 2025 earnings on November 4, 2025 before market open.
What were Beam Therapeutics's Q3 2025 revenue and EPS?
Beam Therapeutics reported revenue of $9.7M and eps of $-1.10 for Q3 2025.
Did Beam Therapeutics beat estimates in Q3 2025?
Revenue missed the consensus estimate of $13.2M by $3.5M. EPS missed the consensus estimate of $-0.98 by $0.12.
How did Beam Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 32.0% from $14.3M a year earlier and eps grew 6.0% from $-1.17.
Where can I find Beam Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-263536) and the 10-Q periodic report (0001193125-25-263542) directly on SEC EDGAR. The filing index links above go to sec.gov.